Discontinued — last reported Q2 '24
Humana AFS Securities increased by 840.6% to $4.64B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 11.0%, from $5.21B to $4.64B. Over 4 years (FY 2021 to FY 2025), AFS Securities shows a downward trend with a -10.8% CAGR.
An increase reflects capital allocation toward investment portfolios, while a decrease may signal portfolio rebalancing or asset liquidation.
Available-for-sale securities are debt or equity investments that are not classified as trading or held-to-maturity, and...
Common in the investment portfolios of banks and insurance companies.
fin_afs_securities| Q4 '21 | Q4 '22 | Q1 '23 | Q2 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $780.00M | $380.00M | $3.94B | $4.23B | $382.00M | $5.20B | $5.09B | $5.58B | $421.00M | $5.21B | $5.29B | $4.61B | $493.00M | $4.64B |
| QoQ Change | — | -51.3% | +937.1% | +7.2% | -91.0% | >999% | -2.2% | +9.8% | -92.5% | >999% | +1.4% | -12.8% | -89.3% | +840.6% |
| YoY Change | — | -51.3% | — | — | +0.5% | +31.9% | +20.4% | — | +10.2% | +0.3% | +3.9% | -17.4% | +17.1% | -11.0% |